NASDAQ:VIVO
Delisted
Meridian Bioscience Inc. Stock News
$33.97
+0 (+0%)
At Close: Apr 28, 2023
Why Infinity Pharma, Meridian Bio, More Biotech Stocks Are Moving Today
12:34pm, Friday, 05'th Feb 2021
Infinity Pharmaceuticals (NASDAQ: INFI) shares are trading higher Friday after JPMorgan upgraded the stock from Underweight to Neutral. Infinity Pharmaceuticals is a clinical-stage biopharmaceutical c
Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q1 2021 Results - Earnings Call Transcript
12:26pm, Friday, 05'th Feb 2021
Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q1 2021 Results - Earnings Call Transcript
Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates
09:50am, Friday, 05'th Feb 2021
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 54.76% and 1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Meridian Bioscience: Q1 Earnings Insights
07:47am, Friday, 05'th Feb 2021
Shares of Meridian Bioscience (NASDAQ:VIVO) moved higher by 5.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 550.00% year over year to $
Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
07:30am, Friday, 05'th Feb 2021
CINCINNATI, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2020.
Why Meridian (VIVO) Might Surprise This Earnings Season
09:50am, Thursday, 04'th Feb 2021
Meridian (VIVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Biotech Bonanza: COVID Launches Science at Warp Speed
07:41pm, Wednesday, 03'rd Feb 2021
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown
10:30am, Wednesday, 03'rd Feb 2021
CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase
What's in Store for Meridian Bioscience's (VIVO) Q1 Earnings?
10:36am, Tuesday, 02'nd Feb 2021
Meridian Bioscience's (VIVO) fiscal first-quarter results are likely to reflect strong performance by Life Science business line.
Meridian's Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
08:00am, Tuesday, 02'nd Feb 2021
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that i
Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know
06:48pm, Friday, 29'th Jan 2021
In the latest trading session, Meridian Bioscience (VIVO) closed at $22.10, marking a +1.33% move from the previous day.
Meridian Bioscience (VIVO) Gains As Market Dips: What You Should Know
06:48pm, Thursday, 14'th Jan 2021
Meridian Bioscience (VIVO) closed at $22.13 in the latest trading session, marking a +1.33% move from the prior day.
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021
04:30pm, Wednesday, 13'th Jan 2021
CINCINNATI, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal 2021
Meridian Bioscience: Benefiting From A Prolonged Pandemic
03:03am, Saturday, 09'th Jan 2021
Meridian could expand its testing supply windfall in 2021, as the world grapples with containing mutations of the COVID-19 virus. Balance sheet safety, profit margins, revenue growth, and current valu
Bull of the Day: Meridian Bioscience (VIVO)
07:32am, Friday, 08'th Jan 2021
Bull of the Day: Meridian Bioscience (VIVO)
